The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Stroke prophylaxis in atrial fibrillation: who gets it and who does not?
Abstract
AIMS: Underuse of warfarin for stroke prophylaxis in atrial fibrillation (AF) is extensive and represents a major problem in clinical practice. To identify factors associated with warfarin treatment in eligible AF patients. METHODS AND RESULTS: The study population consisted of all Swedish resident AF patients at the Stockholm South General Hospital during 2002 (n=2796). Medical records were examined and complemented by data from the Swedish National Hospital Discharge Register. Sixty-eight percent of the patients (1898/2796) had indications, and no apparent contraindications for warfarin treatment. Of these 54% (1029/1898) got warfarin. Factors favouring warfarin treatment after adjustment for other factors were history of ischaemic stroke, an implanted pacemaker, treatment in a cardiology rather than internal medicine ward and valvular defect. Factors associated with a reduced likelihood of warfarin treatment were paroxysmal type of AF and age >80 years. Important risk factors for stroke in AF like heart failure, hypertension, and diabetes did not increase the chances of warfarin treatment. CONCLUSION: Risk stratification using known risk factors of stroke seems to affect warfarin treatment only to a minor degree in clinical practice. Undertreatment was particularly common in patients with paroxysmal AF and in patients aged >80 years and calls for improved clinical routines in accordance with international guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
An exploratory technique for investigating large quantities of categorical data
Kass, G. V. (1980) · Applied Statistics · doi:10.2307/2986296 · Cited by 2,880
Kannel, W. B., Wolf, P. A., Benjamin, E. J., & Levy, D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00583-9 · Cited by 2,033 · cited 1×
“Current disease Ischaemic heart disease 35% (123) 51% (477) 33% (265) 55% (388) 45% (1253) Heart failure 32% (112) 54% (500) 32% (259) 58% (409) 46% (1280) Valvular defect 29% (101) 31% (288) 21% (172) 32% (230) 28% (791) Hypertension 50% (177) 54% (502) 45% (364) 46% (330) 49% (1373) Diabetes mellitus 14% (50) 16% (1…”
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study
Wolf, P. A., Dawber, T. R., Thomas, H. E., & Kannel, W. B. (1978) · Neurology · doi:10.1212/wnl.28.10.973 · Cited by 1,526
Atrial Fibrillation: A Major Contributor to Stroke in the Elderly: The Framingham Study
Wolf, P. A. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090041008 · Cited by 1,108 · cited 1×
“Intracranial bleeding 1% (2) 2% (23) 1% (9) 4% (25) 2% (59) Myocardial infarction 10% (35) 20% (187) 15% (121) 27% (189) 36% (532) Hospital admission for alcohol abuse 5% (16) 5 (1%) 9% (73) 4% (27) 4% (121)”
Gage, B. F., van Walraven, C., Pearce, L., Hart, R. G., Koudstaal, P. J., Boode, B. S. P., & Petersen, P. (2004) · Circulation · doi:10.1161/01.cir.0000145172.55640.93 · Cited by 749
Fang, M. C., Singer, D. E., Chang, Y., Hylek, E. M., Henault, L. E., Jensvold, N. G., & Go, A. S. (2005) · Circulation · doi:10.1161/circulationaha.105.553438 · Cited by 469
Savelieva, I., & Camm, A. J. (2000) · Journal of Interventional Cardiac Electrophysiology · doi:10.1023/a:1009823001707 · Cited by 339
Cited by
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., Lip, G. Y. H., & Manning, W. J. (2008) · Chest · doi:10.1378/chest.08-0678 · Cited by 751
Friberg, L., Rosenqvist, M., & Lip, G. Y. H. (2012) · Circulation · doi:10.1161/circulationaha.111.055079 · Cited by 454
Self-citationAndersson, T., Magnuson, A., Bryngelsson, I.-L., Frøbert, O., Henriksson, K. M., Edvardsson, N., & Poçi, D. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs469 · Cited by 449
Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation
Friberg, L., Hammar, N., & Rosenqvist, M. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehn599 · Cited by 380
Self-citationAtrial Fibrillation, Stroke Risk, and Warfarin Therapy Revisited: A Population-Based Study
Björck, S., Palaszewski, B., Friberg, L., & Bergfeldt, L. (2013) · Stroke · doi:10.1161/strokeaha.113.002329 · Cited by 334
Self-citation
Metadata
- Authors
- Friberg, L., Hammar, N., Ringh, M., Pettersson, H., & Rosenqvist, M.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-07-17
- Volume
- 27
- Issue
- 16
- Pages
- 1954-1964
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2105486760
- Cited by
- 175
- References
- 8
- FWCI
- 7.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stroke prophylaxis in atrial fibrillation: who gets it and who does not? https://app.cochat.ai/papers/10.1093/eurheartj/ehl146
- The paper
- Friberg, L., Hammar, N., Ringh, M., Pettersson, H., & Rosenqvist, M. (2006). Stroke prophylaxis in atrial fibrillation: who gets it and who does not? European Heart Journal. https://doi.org/10.1093/eurheartj/ehl146
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.